Evidence for Coverage Decisions
Real World Data
Budget Impact Analyses Get Some Respect
Using Real-World Data for Coverage and Payment Decisions
Principles of Good Practice for Budget Impact Analysis
The Cost-Effectiveness of Bisphosphonates in Postmenopausal Women Based on Individual Long-Term Fracture Risks
Time from Sexually Transmitted Infection Acquisition to Pelvic Inflammatory Disease Development
Cost-Effectiveness of Switching to Exemestane after 2 to 3 Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer
Economic Evaluation of a Bayesian Model to Predict Late-Phase Success of New Chemical Entities
The Distribution of the Cost of Multiple Sclerosis in the UK
Quality of Life Assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of Patients on Renal Replacement Therapy
Item-Based versus Subscale-Based Mappings from the SF-36 to a Preference-Based Quality of Life Measure
Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients
Measuring Patient Preferences for Colorectal Cancer Screening Using a Choice-Format Survey
Comparison of Persistence Rates with Angiotensin-Converting Enzyme Inhibitors Used in Secondary and Primary Prevention of Cardiovascular Disease